OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call August 4, 2026 4:30 PM EDT
Company Participants
David Bailey – President, CEO & Director
Fred Hite – CFO, Principal Financial & Accounting Officer, COO and Director
Conference Call Participants
Philip Taylor – Gilmartin Group LLC
Frederick Wise – Stifel, Nicolaus & Company, Incorporated, Research Division
Caitlin Roberts – Canaccord Genuity Corp., Research Division
Mathew Blackman – TD Cowen, Research Division
Ravi Misra – Truist Securities, Inc., Research Division
Benjamin Haynor – Lake Street Capital Markets, LLC, Research Division
David Turkaly – Citizens JMP Securities, LLC, Research Division
Presentation
Operator
Good afternoon and welcome to the OrthoPediatrics Corp. Second Quarter 2026 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Trip Taylor from the Gilmartin Group for a few introductory comments.
Philip Taylor
Gilmartin Group LLC
Thank you for joining today’s call. With me from the company are David Bailey, President and Chief Executive Officer, and Fred Hite, Chief Operating and Financial Officer. Before we begin today, let me remind you that the company’s remarks include forward-looking statements within the meaning of federal securities laws, including the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties, and the company’s actual results may differ materially.
For a discussion of risk factors, I encourage you to review the company’s most recent annual report on Form 10-K, which was filed with the SEC on March 4, 2026, and its subsequent quarterly reports on Form 10-Q. During the call today, management will also discuss certain non-GAAP financial measures, which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period over period.
For each